-
MiCAN Technologies, Inc.
The ongoing pandemic continues to shake our world. In order to realize global recovery and a return to normalcy, we will need a robust selection of effective vaccines and treatment options. To accelerate that process, MiCAN Technologies has introduced Mylc, a product line of artificially-produced human cells provided at precise, customizable specifications for use in testing and research. Mylc allows for dramatic improvements in speed and efficiency when studying and developing treatments for COVID-19 and other viral diseases, including dengue…
-
MediGear International Corporation
The leading cause of death in Japan is cancer. While advances in treatment are leading to more lives saved, 2.6% of all cancer patients or about 500,000 sufferers worldwide are not receiving treatment. They give up their treatment because the physical and financial tolls are too onerous and/or an effective treatment method is unavailable. The therapeutic nanodevices being developed by MediGear International are trying to bring a ray of hope to the neglected cancer patients, known as “cancer refugees. Increased…